Litcius/Paper detail

Utilization of Glucagon-Like Peptide-1 Receptor Agonist at the Time of Total Hip Arthroplasty for Patients Who Have Morbid Obesity

Billy I. Kim, Tyler Khilnani, Scott M. LaValva, Susan M. Goodman, Alejandro González Della Valle, Gwo‐Chin Lee

2024The Journal of Arthroplasty23 citationsDOI

Topics & Concepts

AgonistGlucagon-like peptide-1MedicineMorbid obesityTotal hip arthroplastyObesityReceptorInternal medicineGlucagon-like peptide 1 receptorDiabetes mellitusEndocrinologySurgeryType 2 diabetesWeight lossBariatric Surgery and OutcomesTotal Knee Arthroplasty OutcomesHyperglycemia and glycemic control in critically ill and hospitalized patients
Utilization of Glucagon-Like Peptide-1 Receptor Agonist at the Time of Total Hip Arthroplasty for Patients Who Have Morbid Obesity | Litcius